Episode 223: ASCO GU 2023: Discussing KEYNOTE...

Tanya Dorff joins Tom and Brian to discuss her ASCO 2026 data on a novel dual targeting ADC in prostate cancer. The broader scope of ADC development in prostate cancer is discussed with a focus on cytopenia toxicity and future direcctions. 

This comprehensive podcast covers the latest advances in prostate, bladder, and kidney cancers from ASCO 2026, including new therapies, trial data, and practice-changing insights. Brian, Tom and Silke analyze recent studies, controversies, and future directions in GU oncology. 

The May 2024 replay features four episodes on neuro-oncology for brain cancer awareness month. The episode begins with Dr. Philipp Karschnia discussing the assessment of whether MTHFR polymorphisms affect the risk for leukoencephalopathy. The episode continues with Dr. Ingo Melli ...  Show more

Dr. Lauren Kim discusses results from the 20-year follow-up of the International Early Lung Cancer Action Program with Dr. Claudia Henschke, Dr. Rowena Yip, and Dr. David Yankelevitz. A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP). Henschke an ...  Show more

<span class= "normaltextrun"><span style= "font-size: 11.0pt; line-height: 107%; font-family: 'Calibri',sans-serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-theme-font: major-fareast; mso-ansi-language: EN-US; mso-f ...

Dr. Refky Nicola interviews Dr. Joshua Solomon and Dr. David Lynch. CT of Post-Acute Lung Complications of COVID-19. Solomon et al. Radiology 2021; 301:E383–E395.  Introduction by Dr. Linda Chu